chr6-32828908-A-G
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBA1
The NM_001290043.2(TAP2):āc.2059T>Cā(p.Ter687GlnextTer17) variant causes a stop lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 1,543,082 control chromosomes in the GnomAD database, including 58,879 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. *687*) has been classified as Likely benign.
Frequency
Consequence
NM_001290043.2 stop_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAP2 | NM_001290043.2 | c.2059T>C | p.Ter687GlnextTer17 | stop_lost | 12/12 | ENST00000374897.4 | |
TAP2 | NM_018833.3 | c.1932+492T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAP2 | ENST00000374897.4 | c.2059T>C | p.Ter687GlnextTer17 | stop_lost | 12/12 | 1 | NM_001290043.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.274 AC: 41592AN: 151740Hom.: 5915 Cov.: 30
GnomAD3 exomes AF: 0.316 AC: 47140AN: 148998Hom.: 7808 AF XY: 0.318 AC XY: 25415AN XY: 80040
GnomAD4 exome AF: 0.270 AC: 376064AN: 1391224Hom.: 52954 Cov.: 39 AF XY: 0.274 AC XY: 187494AN XY: 685394
GnomAD4 genome AF: 0.274 AC: 41625AN: 151858Hom.: 5925 Cov.: 30 AF XY: 0.282 AC XY: 20934AN XY: 74220
ClinVar
Submissions by phenotype
MHC class I deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at